MUMBAI: The domestic formulation drug market grew by 15.3Pct in August to Rs 9,643 crore over the corresponding month last year.

The growth was driven by 9.1Pct expansion in volumes, 2.9Pct rise in prices and 3.3Pct in new launches, according to the data compiled by pharma market research company AIOCD AWACS.

Indian companies grew by 17.1Pct against 9 Pct growth for MNC pharma companies during the month.

Amongst the top 50 MNCs, Janssen grew by 23.2 Pct followed by Sanofi at 13.4 Pct and Abbott at 12.6Pct over the same month last year.

Among the top 50 Indian corporates, Centaur had the highest growth rate at 42.5% followed by Bharat Serums at 34.4Pct , Apex at 34 Pct and Indoco Remedies at 33.7 Pct.

Following the regulatory ban on fixed dose combination, this segment showed a huge volume de-growth of 16.8%. In revenue terms, Indian companies degrew by 11.1Pct in the FDC portfolio whereas the MNCs degrew by 16.1Pct, the data said.

Read Also: Clinton, Trump In Virtual Dead Heat On Eve Of 1st Debate

Clinton Trump Tied In 13 Battle Ground States Poll